Crohn’s disease affects millions of people worldwide, with an estimated 565,000 Americans living with the condition based on insurance data, though broader survey estimates place total U.S. inflammatory bowel disease (IBD) cases between 2.4 and 3.1 million. Globally, prevalence varies dramatically by region, from as high as 322 per 100,000 people in Germany to as low as 1.5 per 100,000 in Romania.
Prevalence in the United States
Crohn’s disease and ulcerative colitis are the two main forms of IBD, and they occur at roughly similar rates. In the U.S., an estimated 565,000 people have Crohn’s specifically, compared to about 593,000 with ulcerative colitis. Among adults, the prevalence of Crohn’s is approximately 241 per 100,000 people. In children, it’s about 58 per 100,000, making it more common than ulcerative colitis in younger age groups (34 per 100,000).
These numbers have been climbing. The CDC’s most recent estimates suggest the total IBD population in the U.S. may now be substantially higher than older figures indicated, reaching up to 3.1 million adults when based on national survey data rather than insurance claims alone. That gap likely reflects undiagnosed or undertreated cases that don’t show up in medical billing records.
Where Rates Are Highest and Lowest
Crohn’s disease is not evenly distributed across the globe. The highest prevalence rates appear in Western and Northern European countries, along with Australia. Germany leads at 322 per 100,000, followed by Australia at 306 per 100,000 and the UK at 26 per 100,000. New Zealand has the highest incidence rate (new cases per year) at 26 per 100,000, with Denmark close behind at 15.6 per 100,000.
In contrast, many countries in South and Southeast Asia report dramatically lower rates. The Philippines has an incidence of just 0.16 per 100,000, Indonesia 0.25 per 100,000, and Thailand 0.28 per 100,000. Prevalence in China sits at only 3.65 per 100,000. These gaps are enormous, spanning a roughly 200-fold difference between the highest and lowest prevalence countries, and they point strongly to environmental and lifestyle factors playing a major role alongside genetics.
Rates Are Rising in Developing Countries
One of the most notable trends in Crohn’s epidemiology is the sharp rise in newly industrialized regions. Countries that were previously almost untouched by IBD have seen rapid increases since the turn of the 21st century, typically starting with ulcerative colitis and followed by rising Crohn’s diagnoses. This pattern mirrors what happened in Western nations decades earlier and tracks closely with urbanization, dietary shifts toward processed foods, and changes in sanitation that may alter gut bacteria exposure in early life.
Despite earlier assumptions that urban living would produce significantly higher rates than rural areas, U.S. data from 2015 showed surprisingly similar prevalence across settings: about 1.4% in suburban areas, 1.0% in central cities, and 1.2% in rural communities. This suggests that once a country reaches a certain level of industrialization, the urban-rural gap narrows considerably.
Who Gets Diagnosed and When
Crohn’s disease has a bimodal age pattern, meaning diagnoses cluster around two peaks: one near age 20 and another near age 50. The first peak is far more common and tends to involve more aggressive disease, with a greater likelihood of complications and a stronger connection to family history. People diagnosed young are more likely to have a close relative with the condition, supporting the idea that early-onset Crohn’s has a stronger genetic component.
Sex differences are real but complicated. In Western countries, boys are more likely to develop Crohn’s before puberty, but after puberty the pattern flips, and women carry a slightly higher overall risk through adulthood. In Asian-Pacific countries, men remain at higher risk from adolescence through age 50. Women with Crohn’s tend to experience earlier disease onset and are more likely to develop symptoms outside the gut, including joint inflammation and skin conditions. When surgery is needed, the time before disease recurrence is shorter in women (about 4.8 years compared to 6.5 years in men).
Crohn’s in Children
Pediatric Crohn’s is becoming more common. The incidence in children ranges from 2.5 to 11.4 per 100,000 depending on the population studied, with a prevalence of about 58 per 100,000. Along with rising diagnosis rates, hospitalizations and the need for intestinal surgery in children have also increased. Crohn’s diagnosed in childhood often involves more of the digestive tract and carries a higher risk of complications over a lifetime, partly because there are simply more years for the disease to progress.
What This Means for Life Expectancy
People with Crohn’s disease do have a shorter life expectancy on average compared to the general population. A Canadian study tracking outcomes from 1996 to 2011 found that women with IBD lived 6.6 to 8.1 fewer years than women without it, while men with IBD lived 5.0 to 6.1 fewer years. These are averages across all severities and ages of diagnosis, so individual outcomes vary widely.
The encouraging trend is that the gap is narrowing. Life expectancy for women with Crohn’s increased by about 2.9 years over that 15-year study period, and for men it increased by about 3.2 years. Improvements in treatment, earlier diagnosis, and better disease monitoring are all contributing to longer, healthier lives for people with the condition. The gap between people with and without IBD persists, but it’s smaller than it was a generation ago.